RenovoRx (RNXT) Earnings Date & Reports

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RNXT is expected to report earnings to fall 16.67% to -7 cents per share on August 13

Q2'26

Est.

$-0.08

Q1'26

Missed

by $0.01

Q4'25

Est.

$-0.08

Q3'25

Est.

$-0.08

Q2'25

Beat

by $0.01

The last earnings report on May 14 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 129.58K shares outstanding, the current market capitalization sits at 38.05M.

View a ticker or compare two or three

Compare

RNXT

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for RNXT